Global and Local Pharmacovigilance Services, since 2008

Prabjot Hunjan joins Arriello
as Director of Global Drug Safety.

Arriello welcomes another senior pharmacovigilance leader to our growing team of PV experts.

Prabjot joins Arriello’s Pharmacovigilance team with over 16 years of experience across both clinical trials and post-marketing within European and Global PV operations, both in CROs and pharma, and with six years in management.

His CRO & pharma experience includes director-level management, leading and developing the Pharmacovigilance function whilst delivering Pharmacovigilance Quality and Process Improvements.

Prabjot has also acted as EU QPPV and Deputy on behalf of Marketing Authorization Holders in the EU and has worked within a large team as a program and product lead on a well-established MS product. 

Prabjot is also a trained auditor and experienced in EU GDPR as a Data Protection Officer.

He will report to Arriello’s VP of Global Dug Safety @kieranodonnell

Latest news.

View all
We have opened a new West Coast office location right in the heart of Biotech Bay, South San Francisco at 611 Gateway Blvd, Suite 120.
San Francisco Skyline
Kieran and Nicola speaking about our latest US/UK/EU survey which provides initial feedback from senior PV and Reg professionals across 4 countries on the EMA’s new Clinical Trials Regulation (CTR) that will be fully applicable from January 31 2023.
Events BIO europe
Peter Embley joins Arriello to lead it’s Regulatory Affairs team and comes with over 24 years of experience working across the Pharmaceutical, CRO and Consulting Industries.
Pete Embley News